Medochemie Ltd was established in 1976 in Cyprus by Dr Andreas Pittas. Our base is in Europe, but we have activities expanding from the Middle East & Africa, through to the Far East and the Americas. We have acquired and maintain 3,800 marketing authorisation licences for 630 different pharmaceutical products, classified in over 10 therapeutic categories. We operate in accordance with the strictest quality standards and in full compliance with European guidelines. The driving force behind Medochemie is our 1370 multinational, talented, quality-focused employees, who work in our manufacturing plants and offices worldwide. Medochemie is a founding member of the Medicines for Europe (former EGA). The participation of Medochemie (large enterprise) is beneficial to the project in that it expands the project scope and number of expected project results, with a very modest sum of funding (2400 Eur). Accomplishing the same results through the external services route would have been more costly.

 Key Personnel

Dr Christakis A. Sergides is the head and coordinator of the Analytical and Research Chemistry Labs, Medochemie Ltd, since 1996. He is a reviewer of research scientific journals of Spandidos Publications, and a qualified person, registered with pharmaceutical authorities, Minister of Health, Cyprus. Prior to joining Medochemie, Dr. Sergides was a visiting scientist at the Department of Chemistry, University of Denver, U.S.A. (1995), and a chemist and plant manager of Shell Lubricating plant (1987 – 1994). He held a postdoctoral fellowship at the Department of Chemistry, University of Denver, U.S.A. in 1985 – 1986, using a variety of chemical analytical methods such as gas chromatography/mass spectrometry (GC/MS), Raman, Carbon – 13CP/MAS NMR, Fourier Transform Infrared Spectroscopy, Electrochemical analysis, microgravimetry, scanning electron microscopy and the classical BET surface area determination, to study the structure of n-hexane soot. Also, the physicochemical reactivity of soot with other atmospheric pollutants such as ozone, oxides of nitrogen and sulphur was examined. These studies won the American Chemical Society Research Award. Dr. Sergides received his PhD from the University of Denver (Department of Chemistry, 19811985). He has participated in extensive training session throughout his career, and is an expert in identification of the molecules using different FTIR techniques such as infrared reflection or transmission methods, involving the measurement of drug samples for the identification of functional groups of drug substances. He has published his work in peer reviewed journals.